NeoGenomics
#4175
Rank
$2.06B
Marketcap
United States
Country
Mr. George A. Cardoza (Pres & COO of Lab Operations)
Ms. Kathryn B. McKenzie (Interim Chief Culture Officer, Chief Sustainability & Risk Officer)
Mr. Christopher Michael Smith BSc (CEO & Director)
Summary
History
NeoGenomics was founded in 2001 by a group of oncologists, pathologists, and entrepreneurs with a passion for improving patient care through improved molecular diagnostics. Initially, NeoGenomics prepared and interpreted a variety of clinical testing including cytogenetics, disomy analyses, FISH, and CGH arrays. After years of investing in inventory, infrastructure and personnel, the company has become a full-service provider of clinical laboratory services for pathologists, oncologists, urologists and other clinical authorities.
Mission
Vision
innovative solutions, we will be the world’s leading cancer testing and information company.
Key Team
Mr. Jeffrey S. Sherman M.B.A. (Chief Financial Officer)
Mr. Hutan Hashemi J.D. (Chief Compliance Officer)
Ms. Cynthia J. Dieter (Chief Accounting Officer)
Ms. Ali Olivio (Gen. Counsel & Corp. Sec.)
Mr. John Mooney (Chief Technology Officer)
Dr. Shashikant Kulkarni Facmg, M.B.A., M.S., Ph.D. (Pres of Lab Operations & Chief Scientific Officer)
Charlie Eidson (Director of Investor Relations and Corp. Devel.)
Recognition and Awards
References
https://en.wikipedia.org/wiki/NeoGenomics
https://in.investing.com/equities/neogenomics-inc
https://finance.yahoo.com/quote/NEO/profile?p=NEO
https://www.comparably.com/companies/neogenomics-laboratories/mission
https://www.crunchbase.com/organization/neogenomics-laboratories
https://sec.report/CIK/0001077183
Mr. George A. Cardoza (Pres & COO of Lab Operations)
Ms. Kathryn B. McKenzie (Interim Chief Culture Officer, Chief Sustainability & Risk Officer)
Mr. Christopher Michael Smith BSc (CEO & Director)